KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Interest Expenses (2016 - 2026)

Bio-Rad Laboratories has reported Interest Expenses over the past 18 years, most recently at $12.3 million for Q1 2026.

  • Quarterly Interest Expenses rose 2.5% to $12.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $49.3 million through Mar 2026, up 1.44% year-over-year, with the annual reading at $49.0 million for FY2025, 0.2% changed from the prior year.
  • Interest Expenses was $12.3 million for Q1 2026 at Bio-Rad Laboratories, up from $12.1 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $12.6 million in Q2 2025 and troughed at $4.0 million in Q1 2022.
  • The 5-year median for Interest Expenses is $12.3 million (2024), against an average of $11.6 million.
  • Year-over-year, Interest Expenses soared 3105.77% in 2022 and then decreased 2.44% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $11.7 million in 2022, then grew by 5.6% to $12.3 million in 2023, then decreased by 0.99% to $12.2 million in 2024, then fell by 0.82% to $12.1 million in 2025, then grew by 1.65% to $12.3 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Interest Expenses are $12.3 million (Q1 2026), $12.1 million (Q4 2025), and $12.3 million (Q3 2025).